Orthopediatrics KIDS Cash Flow Statement (2016-2026)

NASDAQ KIDS
$21.94 -0.28 (-1.27%)
As of: Sep 9, 2026 · 12:07 PM EDT
Reported Financials

Orthopediatrics Quarterly Cash Flow Statement

Periods 40 quarters
Latest Jun 2026

Orthopediatrics reported cash from operations of $0.93M and free cash flow of -$3.12M for the quarter ended Jun 2026, up 108.9% year over year. This cash flow statement covers 40 quarters of results from Sep 2016 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-2.20M0.07M-9.10M-0.33M18.54M-7.85M-6.81M-2.89M-4.59M-6.69M-7.80M-6.03M-7.92M-16.07M-10.66M-7.11M-11.77M-10.10M-10.69M-7.16M
Share-based CompensationStock Comp.
1.44M1.67M1.53M1.77M1.68M1.70M2.11M3.46M2.37M2.75M2.80M2.94M3.92M3.89M3.86M5.25M4.25M4.42M3.98M4.19M
Deferred Taxes
0.29M0.24M-0.32M-0.44M-4.05M-0.23M-0.57M-0.40M0.08M-0.26M-2.44M-0.51M-0.95M-0.83M0.20M0.05M-0.12M-0.27M-0.31M0.23M
Cash from Discontinued OperationsCash from Discont. Ops
Gains from Investment SecuritiesGains Investment
-1.43M-5.51M2.57M-5.01M-23.01M-0.48M-0.67M-2.30M-0.01M
Asset Writedowns and ImpairmentWritedown
3.61M0.98M1.84M2.35M
Cash from OperationsCash from Ops.
-0.94M-1.24M-4.20M-8.17M-6.06M-3.34M-6.46M-4.37M-8.67M-7.54M-6.69M-6.09M-10.28M-3.99M-4.16M-10.46M-0.58M10.35M-3.29M0.93M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
2.72M2.81M2.96M3.33M3.29M3.52M3.85M4.08M4.27M5.19M5.03M4.78M5.28M3.99M5.05M5.17M5.30M5.60M5.72M5.71M
Change in Working Capital
Change in ReceivablesChange Receivables
-1.06M-0.25M-0.00M6.62M-1.05M-1.58M2.00M6.96M3.91M-3.15M-1.16M5.74M0.59M-0.43M1.50M9.88M-3.11M1.10M0.18M6.35M
Change in InventoryChange Inventory
-0.05M1.81M6.75M4.16M3.91M2.13M5.98M5.88M10.34M4.08M6.63M3.79M3.73M-0.96M1.91M6.99M-1.01M0.58M-0.14M2.69M
Change in Account PayablesChange Payables
-1.15M0.39M5.26M0.04M-5.69M0.18M5.54M4.18M1.77M-10.00M6.56M-2.41M-5.92M-2.51M5.21M-1.49M-5.68M10.13M0.70M2.44M
Change in Accured ExpensesChange Accured Exp.
-1.25M1.26M-0.69M1.82M0.67M1.54M-1.57M2.90M1.96M3.56M-5.05M6.01M-0.65M0.23M-2.53M5.04M-1.72M0.46M-3.57M5.78M
Other Working Capital ChangesOther WC Changes
0.15M0.09M0.22M0.12M-1.24M0.37M0.71M0.94M1.26M1.72M-0.37M2.15M1.27M-3.37M1.56M0.31M-0.19M1.11M-1.28M2.15M
Investing Activities
Capital ExpendituresCapex
1.99M1.64M4.20M5.27M1.09M-0.52M4.94M5.62M2.48M3.84M6.46M6.68M1.38M-0.26M4.23M3.44M2.84M0.60M1.76M4.04M
Acquisitions
-8.36M20.69M-0.47M
Change in Acquisitions & DivestmentsChange Acquisitions
4.00M5.25M18.50M13.10M13.93M1.34M37.25M35.10M16.69M23.86M23.47M26.38M5.00M8.00M
Cash from Investing ActivitiesCash from Investing
-3.04M2.96M14.30M-0.53M-103.92M-23.23M32.31M-18.22M9.67M17.92M-3.68M19.70M-26.77M-2.41M-5.99M-3.54M-26.84M-7.26M-3.79M5.00M
Financing Activities
Other financing activitiesOther financing
0.07M0.04M0.02M0.02M
Cash from Financing ActivitiesCash from Financing
0.04M-0.03M-0.03M27.77M108.27M-0.04M-0.04M-2.04M-0.01M9.39M-0.57M-4.27M58.52M-0.54M-0.13M24.80M-0.28M-0.42M-0.61M-0.74M
Change in Capital Stock
Net Equity Issued and RepurchasedNet Equity Issued
Additional items
Exchange Rate EffectFX Effect
-0.29M-0.39M0.24M0.16M0.03M0.19M-0.14M-0.20M-0.06M1.03M1.48M-2.01M0.68M-0.33M-0.08M0.38M-0.02M0.06M0.31M-0.38M
Change in Cash
-4.23M1.30M10.31M19.23M-1.68M-26.41M25.68M-24.83M0.92M20.80M-9.46M7.33M22.16M-7.27M-10.35M11.18M-27.72M2.74M-7.38M4.81M
Free Cash FlowFCF
-2.93M-2.87M-8.39M-13.44M-7.15M-2.82M-11.40M-10.00M-11.15M-11.38M-13.15M-12.78M-11.66M-3.73M-8.38M-13.91M-3.42M9.75M-5.05M-3.12M
Net Cash FlowNCF
-3.94M1.70M10.07M19.08M-1.71M-26.60M25.81M-24.63M0.98M19.77M-10.94M9.34M21.47M-6.94M-10.27M10.79M-27.70M2.67M-7.69M5.19M